mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.04 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.05 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.05 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.05 |
mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
0.36 |
0.05 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.05 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.05 |